This megastudy is a massive randomized controlled trial. By randomizing participants to 10 different intervention conditions simultaneously, the investigators will be able to compare the effectiveness of different interventions to one another and to a control group (in which individuals will only receive the usual communications from their partner organization) to identify which interventions significantly increase vaccination rates. Pharmacy customers will be randomly assigned to receive one of the interventions designed by team scientists to encourage vaccination or to a control group. The baseline intervention will be based on the top-performing SMS intervention identified in the investigators previous megastudies on encouraging vaccination (Milkman et al., 2021b, 2022). Pharmacy customers will receive SMS messages conveying that a COVID booster vaccine is reserved or waiting for them at the pharmacy. Additional behavioral science messaging strategies will be tested by building off of this baseline intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Enrollment
2,600,000
Participants will receive text messages per descriptions listed in the arms.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Patient uptake of the COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time frame: During the 30 days after receiving the SMS/MMS intervention
Patient uptake of the COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time frame: 60 days after receiving the SMS/MMS intervention
Patient uptake of the COVID bivalent booster
Whether patients receive a bivalent COVID booster at the pharmacy in question
Time frame: 90 days after receiving the SMS/MMS intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.